In this episode of The Diary Of A CEO, Dr. Rachel Rubin and Steven Bartlett discuss the significant gaps in medical training and understanding around women's hormonal health and sexual function. Rubin explains how hormones like testosterone, estrogen, and progesterone affect women throughout their lives, and why the widespread fear of hormone therapy stems from misinterpreted research. She addresses the stark reality that most doctors receive little to no education about female sexual anatomy, pleasure, or common conditions affecting women's sexual health.
The conversation covers practical topics including the role of vaginal hormones in preventing UTIs and treating painful sex, the reasons behind the orgasm gap between men and women, and how factors like birth control, stress, and body image affect libido. Rubin and Bartlett also explore how couples can improve their relationships through open communication about sex, shared education about anatomy and pleasure, and reframing sexual difficulties as medical issues rather than personal failures.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Women's hormonal health is complex and dynamic, yet misconceptions and gaps in medical training often leave women without access to effective treatments. Rachel Rubin and Steven Bartlett discuss how understanding hormones like [restricted term], estrogen, and progesterone—and the options for hormone therapy—empowers women to make informed health decisions.
[restricted term] plays a crucial role in women's libido, arousal, orgasm, and body image. Rubin administers carefully dosed [restricted term]—about one-tenth the male dosage—to women with low libido, and many report improved sexual response within three to six months. [restricted term] levels begin declining in women's thirties, well before menopause, causing reduced libido, diminished arousal and lubrication, and changes in clitoral function. These changes are often unrecognized by both women and physicians.
Combined birth control pills suppress ovarian [restricted term] production, which Rubin notes leads to diminished libido and pain during sex in some women. Studies indicate up to 27% of those on birth control report reduced sexual drive. Rubin emphasizes the importance of discussing alternative contraceptives for those negatively affected.
Perimenopause, typically occurring between ages 35 and 45, marks the beginning of hormonal fluctuations. Symptoms range widely—from temperature regulation issues, fatigue, memory problems, and low libido, to joint pain, irregular bleeding, painful sex, and increased UTIs. Many symptoms are attributed to other causes due to insufficient focus on hormones in medical education.
True menopause, typically between 45 and 55, occurs when ovarian estrogen production ceases entirely. This triggers hot flashes, night sweats, osteoporosis, depression, low libido, vaginal tissue atrophy, and metabolic syndrome. Progesterone decline can disrupt sleep and increase anxiety, though distinguishing between progesterone and estrogen symptoms is challenging.
A pivotal moment arose from the early 2000s Women's Health Initiative study, which hastily linked hormone therapy to cardiovascular disease and breast cancer. The study was stopped early and publicized as evidence against hormone therapy. However, subsequent analysis clarified that hormone therapy is safe for women under 70, with no increased risk of breast cancer or cardiovascular events. Despite these clarifications, the initial panic persists.
Today, only 1.7% of eligible women receive hormone therapy due to gaps in physician training, lingering misconceptions, and safety fears. Rubin highlights how misinformation from previous generations still shapes present attitudes.
Hormone therapy should be individualized based on symptoms. Estrogen addresses hot flashes, bone health, and metabolic support. Progesterone provides uterine protection, sleep augmentation, and anxiety reduction. [restricted term] specifically targets libido and arousal. Vaginal hormones—local microdoses of estrogen or DHEA—support bladder and vaginal health, improving dryness, pain during sex, and reducing UTIs without systemic risk.
Vaginal hormones—microdosed [restricted term] creams or tablets used twice weekly—cost between 90 cents and $14 for several months' supply. These treatments lower the risk of UTIs by over 50%, significantly reduce urinary frequency and urgency, eliminate pain and dryness during sex, and enhance arousal and orgasm. Rubin describes them as "better than [restricted term]" for women's sexual function.
Vaginal hormones restore the acidic environment, support the protective microbiome, and suppress pathogens far more effectively than post-coital urination or cranberry supplements. For those who struggle with creams or forget regular dosing, [restricted term]-releasing vaginal rings offer a convenient three-month alternative.
Current guidelines often insist on twelve months without menstruation before confirming menopause and recommending HRT. Rubin argues this approach is outdated—women experiencing sleep disruption, low libido, urinary or sexual pain in their 30s, 40s, and early 50s should not wait for full ovarian failure. Early, symptom-targeted intervention can immediately improve quality of life.
Postpartum lactation creates temporary menopause with manageable symptoms. After childbirth, estrogen and progesterone levels plummet, and women may experience hot flashes, night sweats, sexual pain, and urinary complaints—symptoms readily treatable with local vaginal hormones that are safe for mother and child. Early hormone therapy may also prevent long-term complications like bone loss, fractures, and vascular issues.
Rubin highlights that about 20% of women report never experiencing orgasm, a stark contrast to men. This gap stems not from female physiology, but from lack of education around sexual anatomy and pleasure. Many women believe orgasm should result from penetrative sex, but for most women, clitoral stimulation is key. The misconception is so widespread that women frequently see themselves as "broken" when they don't orgasm from penetration alone.
Rubin explains that penetration alone often brings as little chance of orgasm as rubbing a thigh. Vibration on the clitoris, manual stimulation, or specific devices commonly produce pleasure and orgasm. Time frames also differ significantly: men average five and a half minutes from penetration to orgasm, while women require much longer—often over 13 to 15 minutes, usually with added clitoral focus.
Educational gaps are glaring. Most women cannot locate their clitoris and don't realize it plays a central role in orgasm. The word "clitoris" is still omitted from required training checklists for OBGYNs.
Rubin dismantles the myth of the clitoris as a small, external "button." It is a vast organ, extending internally down to the butt bones and containing approximately 10,000 nerve endings. Yet, medical practitioners rarely examine it or discuss its function or possible dysfunction.
Roughly 23% of women can develop clitoral adhesions, where the hood becomes stuck to the clitoral head. When identified, a straightforward office procedure can remove these adhesions, leading to substantial improvements in arousal, orgasm, and satisfaction in 60–70% of affected patients. Despite these benefits, lack of provider training and patients' unfamiliarity with their own anatomy are common barriers to diagnosis and treatment.
The pelvic floor muscles can become dysfunctional due to surgery, childbirth, trauma, hormonal changes, or overuse. Poor pelvic floor function can impair sexual pleasure by causing pain, reducing blood flow, and disrupting the brain-genital connection needed for arousal and orgasm. Specialized physical therapists can assess muscle strength and coordination, teaching patients to strengthen or relax these muscles for better sexual function.
Painful intercourse is prevalent: up to 75% of women experience it at some point, and 10–20% suffer from chronic pain during sex. Causes are diverse: skin and tissue issues, muscle dysfunction, nerve compression, endometriosis scars, and other medical conditions. Rubin stresses that sex should not be painful, and women deserve a thorough diagnostic workup and tailored treatment.
Rubin describes a fundamental mismatch in many heterosexual encounters: men seek reassurance about the size, hardness, and duration of their erections, mistakenly believing these factors drive female satisfaction. In reality, women's pleasure is far more dependent on clitoral stimulation, foreplay, and arousal built through physical and emotional connection. Women's arousal styles differ: spontaneous arousal occurs in only 10–15% of women compared to 70% of men, while 40–50% of women require responsive arousal once physical contact begins.
Pornography traffic is predominantly male, and men between 18 and 35 are far more regular users than women. The vast majority of pornography depicts intercourse as the trigger for female orgasm, a misleading script for real-life relationships. Many women fake orgasms to meet their partner's expectations, perpetuating misunderstanding. Porn also warps expectations about body types, stamina, and performance.
Heavy pornography use is associated with lower relational and sexual satisfaction, as repeated exposure desensitizes the brain's reward system and generates expectations that real partners cannot meet. This often leads to performance anxiety, erectile difficulties, and secrecy or deception. Discovering a partner's hidden pornography use can trigger intense feelings of betrayal and rejection.
The American medical system consistently fails women, particularly in sexual health, menopause, and hormone therapy. These failures stem from fundamental education gaps, outdated practices, and systemic bias.
Rubin illustrates that even the wealthiest women—like Melinda Gates, Oprah Winfrey, and Halle Berry—struggle to obtain competent hormone therapy and accurate menopause diagnosis. Gates visited three doctors to get appropriate prescriptions; Oprah saw five physicians who missed her perimenopausal symptoms, and Berry received a misdiagnosis of genital herpes, later revealed to be genitourinary syndrome of menopause.
The word "clitoris" does not exist on the official training checklist for OB-GYNs as of 2026. This means most OB-GYNs graduate with no formal education on sexual health, sexual pain, libido, arousal, or orgasm. In contrast, male sexual anatomy and dysfunction have entire fields dedicated to their care.
Rubin highlights a critical double standard: without training or full knowledge of the data, doctors often dictate to women what they can and cannot have regarding hormone therapy, rather than engaging in shared decision-making. In men's health, practitioners routinely discuss options openly with patients.
Structural limitations erode quality care. Rubin states it's impossible to provide personalized medical advice in a standard 10-minute visit. Twenty years of fear and misinformation about hormone therapy created a generation of providers unable to prescribe or explain hormone therapy confidently. Although medical research continues to advance, translating this data into clinical reality lags significantly.
Research funding systematically neglects the sexual health of women, especially regarding medication side effects. A recent survey of 1,000 women taking GLP-1 weight-loss drugs found that about 25% experienced sexual side effects, yet there are no published studies on these effects—even as there are many published on metabolic and reproductive outcomes. Rubin notes that the medical establishment prioritizes research on medication effects for women's reproductive capacity while largely ignoring their sexual health, pleasure, and satisfaction.
Open communication, vulnerability, and ongoing sexual health education form the foundation of fulfilling relationships. Rubin and Bartlett explore how misunderstandings, medical factors, and lack of dialogue create persistent challenges.
Many relationship conflicts stem from misinterpreted medical issues. Rubin helps reframe sexual avoidance not as rejection, but as a valid, treatable condition. Understanding female arousal, hormones, pelvic floor function, and pain syndromes helps couples pursue treatment rather than assuming incompatibility. For example, 20-30% of women using hormonal birth control experience decreased libido due to [restricted term] suppression, but most are unaware the medication is to blame.
Both Rubin and Bartlett note that most couples never openly discuss their sex lives. Sensitive topics are buried out of shame or fear, sometimes for years. Women often fake orgasms to please partners. Rubin emphasizes the need for conversations "about sex when you're not having sex," suggesting partners debrief after sexual experiences and express curiosity spilling into daily life.
Contrary to popular belief, sexual spontaneity is rare in long-term relationships. Rubin observes that during dating, couples essentially schedule sexual opportunities. Once cohabiting, with life's stresses and exhaustion, expecting spontaneous desire sets an unrealistic standard. She recommends quarterly "partner days," where couples block off uninterrupted time to reconnect, communicate, and rekindle intimacy.
Conflicts around libido differences or sexual pain are not moral failings. Rubin and Bartlett emphasize that reframing these issues as shared challenges—"us against the problem"—transforms shame and blame into collaboration and empathy. When partners understand that needs differ, they gain the freedom to problem-solve together.
Education is the bedrock of better relationships and sex. Rubin highlights the transformative effect of learning about anatomy, sexual function, and pleasure. Curiosity, honesty, and shared learning allow couples to navigate differences in needs and preferences. The goal: to approach sexuality as a shared journey requiring teamwork, openness, and compassion.
Modern life exerts powerful influences on sexual wellbeing through stress, cultural expectations, and mental health treatments.
Chronic stress, lack of sleep, burnout, and absence of personal downtime significantly drain [restricted term], leading to decreased libido and sexual dissatisfaction. Bartlett describes personal experiences of lowered libido during periods of extreme overwork. Rubin affirms these patterns, explaining that exhausted, overscheduled individuals lack the energy and mental space needed for sexual connection. Digital stimulation before bed also depletes the parasympathetic nervous system's capacity for arousal.
Perfectionism and insecurity around body image diminish women's sexual confidence and pleasure. Rubin observes that women often invest enormous energy in striving for thinness rather than strength, undermining sexual self-assurance. Some women withhold intimacy from themselves, believing they do not deserve pleasure unless they reach a certain weight. Rubin counters these beliefs by reinforcing that all people are entitled to pleasure and connection.
Mental health treatments, particularly antidepressants, can diminish libido and sexual function even as they relieve anxiety or depression. Rubin highlights the importance of understanding that these side effects are medical, not evidence of a lack of love or attraction. Effective communication and awareness enable couples to seek adjustments rather than passively accepting permanent sexual dysfunction as an inevitable consequence of treatment.
1-Page Summary
Women's hormonal health is dynamic and complex, influencing well-being from early adulthood through menopause and beyond. Misconceptions, stigma, and gaps in physician training often leave women without access to effective treatments. Understanding the roles of hormones such as [restricted term], estrogen, and progesterone—and the options for hormone therapy—empowers women to make informed decisions about their health.
[restricted term] is often perceived as a "male" hormone, but as Rachel Rubin and Steven Bartlett discuss, it is crucial for women as well. [restricted term] supports libido, arousal, orgasm, and overall sexual satisfaction in women. It also plays a significant role in body image and psychological well-being. In clinical practice, Rubin administers carefully dosed [restricted term]—about one-tenth the male dosage—to women experiencing low libido or other sexual concerns, with many reporting improved sexual response and body confidence within three to six months.
[restricted term] levels in women are relatively stable throughout the menstrual cycle but peak during ovulation, supporting evolutionary drives for reproduction. However, [restricted term] production begins to decline in women's thirties, well before menopause. This decrease can manifest as reduced libido, lessened arousal, longer time to orgasm, diminished engorgement and lubrication, and changes in clitoral function—akin to how erections work in men. These subtle but impactful changes are often unrecognized by women and physicians, who may only focus on estrogen and progesterone and overlook [restricted term]'s significance.
Combined birth control pills deliver synthetic estrogen and progestin at levels that suppress ovarian hormone production altogether—including [restricted term]. Rubin notes that in a subset of women, this suppression leads to diminished libido and even pain during sex. Studies indicate up to 27% of those on birth control report reduced sexual drive. Rubin highlights the importance of discussing alternative contraceptives for those negatively affected, as non-hormonal or different hormonal methods may not suppress [restricted term] as much. Real-life experiences, such as Bartlett’s fiancé regaining libido after stopping the pill, reinforce the importance of awareness about this side effect.
Perimenopause, spanning ages 35 to 45, marks the beginning of hormonal fluctuations. Symptoms vary widely—ranging from temperature regulation issues, fatigue, memory problems, and low libido, to dry eyes, itchy ears, joint pain, irregular bleeding, painful sex, and increased incidence of urinary tract infections (UTIs). Many of these symptoms are attributed to other causes or overlooked due to insufficient focus on hormones in medical education.
True menopause—typically between 45 and 55—occurs when ovarian estrogen production ceases entirely. This dramatic loss, a “castration event,” triggers classic menopause symptoms: hot flashes, night sweats, osteoporosis or bone density loss, depression, low libido, vaginal tissue atrophy, and metabolic syndrome, affecting everything from sleep to cardiovascular function.
The decline of progesterone, which begins in perimenopause, can lead to sleep disturbances and heightened anxiety. Distinguishing symptoms caused by declining estrogen from those caused by dropping progesterone is not straightforward, so individualized therapy may combine both, addressing sleep, anxiety, and uterine protection.
A pivotal moment of confusion arose from the early 2000s Women's Health Initiative (WHI) study, which hastily linked hormone therapy to cardiovascular disease and breast cancer. The study, enrolling women aged 50–79 and using hormone formulations uncommon today, was stopped early and publicized as evidence against hormone therapy. However, data analysis and subsequent publications corrected this, clarifying that hormone therapy is safe for women under 70, with no increased risk of breast cancer or cardiovascular events. Despite these clarifications, the initial panic persists.
Today, only 1.7% of eligible women receive hormone therapy. This extreme underuse results from gaps in physician training, lingering misconceptions, and safety fears propagated by outdated or misinterpreted studies. Rubin highlights how misinformation from previous generations still shapes present attitudes, as patients refuse therapy due to unfounded cancer concerns.
Hormone therapy is not one-size-fits-all and is best individualized. Four major components are used depending on a woman's needs:
Treatment can start with vaginal hormones for sexual and urinary comfort, progress to systemic estrogen for vasomotor and bone symptoms, and add progesterone for uterine safety and sleep if the uterus is intact. [restricted term] may be added if libido remains low.
Vaginal hormones—microdosed [restricted term] creams or tablets used twice weekly—cost between 90 cents and $14 for several months’ supply. These treatments:
Women's Hormonal Health Across the Lifespan
Rachel Rubin, a sex doctor and urologist, highlights that about 20% of women report never experiencing orgasm, a stark contrast to men, for whom orgasm problems are much less common. Rubin stresses this gap is not caused by female physiology, but by a lack of education around sexual anatomy and pleasure. Many women believe orgasm should result from penetrative sex because this is the dominant narrative, but for most women, clitoral stimulation is key. The misconception is so widespread that women frequently see themselves as "broken" when they do not orgasm from penetration, even though direct or indirect clitoral stimulation is typically necessary.
Rubin explains that penetration alone often brings as little chance of orgasm as rubbing a thigh, drawing a clear analogy to overturn entrenched beliefs. Vibration on the clitoris, manual stimulation, or use of specific devices commonly produce pleasure and orgasm, while some women find direct clitoral stimulation too intense and prefer different approaches—demonstrating diversity in needs and sensitivity.
Penetration can still be pleasurable or emotionally meaningful for some women, especially when nerve endings on the inner vagina or cervix are particularly sensitive, yet this is only a subset. Rubin suggests that women who orgasm from penetration may have heightened sensitivity, similar to the small percentage of men who experience very rapid ejaculation. In the vast majority, orgasm results from focused clitoral stimulation—penetration is often only one element among many that make up satisfying sexual encounters. She insists every woman's experience is unique and discourages one-size-fits-all assumptions about sexual pleasure.
Time frames for orgasm also differ significantly: men average five and a half minutes from penetration to orgasm, while women, when they do orgasm through penetration (which is uncommon), require much longer—often over 13 to 15 minutes, usually with added clitoral focus. Rubin asserts that high-rate, clockwork-like orgasms for women during penetration are often faked, as many women wish to please their partners or avoid discomfort in communication.
Rubin emphasizes the urgent need to shift focus from penetration to pleasure and clitoral attention, advocating a view of penetration as “part of the story” rather than the central event.
Educational gaps are glaring. Most women cannot locate their clitoris and don’t realize it plays a central role in orgasm. The word “clitoris” is still omitted from required training checklists for OBGYNs—Rubin underscores that no field of medicine systematically teaches its examination or prioritizes its health.
Rubin dismantles the myth of the clitoris as a small, external “button.” It is a vast organ, extending internally down to the butt bones and composed of the same erectile tissue as the penis. Under a microscope, the clitoris closely resembles the penis in structure and function, containing approximately 10,000 nerve endings. Yet, medical practitioners rarely examine it or routinely discuss its function or possible dysfunction.
Roughly 23% of women can develop clitoral adhesions, where the hood becomes stuck to the clitoral head. This issue is often undiagnosed, as doctors rarely examine the clitoris. When identified, a straightforward office procedure can remove these adhesions, leading to substantial improvements in arousal, orgasm, and satisfaction in 60–70% of affected patients. Despite these benefits, lack of provider training and patients’ unfamiliarity with their own anatomy are common barriers to diagnosis and treatment.
Rubin observes that many women (and their partners) have never even seen or discussed their own clitoris, as genital exams are usually performed without patient observation or participation. She encourages open discussion and joint exploration as foundational for understanding pleasure.
The pelvic floor consists of strong muscles encircling the bones of the pelvis, capable of contracting and relaxing. These muscles can become dysfunctional due to surgery, childbirth, trauma, hormonal changes, or overuse. Poor pelvic floor function can impair sexual pleasure by causing pain, reducing blood flow, and disrupting the brain-genital connection needed for arousal and orgasm.
Tight pelvic floor muscles result in burning, soreness, and penetration pain, and may cause weak or absent orgasms and diminished arousal. Pelvic floor dysfunction is correctable: specialized physical therapists can assess muscle strength and coordination, teaching patients to strengthen or relax these muscles for better sexual function and less pain. Both strengthening and relaxation may be needed, depending on individual assessment.
Painful intercourse is prevalent: up to 75% of women experience it at some point in their lives, and 10–20% suffer from chronic pain during sex. During menopause, this number may soar to 20–50% due to hormonal tissue atrophy. Causes are diverse: skin and tissue issues (eczema, autoimmune disorders, hormonal changes), muscle dysfunction, nerve compression (such as from spinal problems), endometriosis scars, and other medical conditions.
Rubin stresses that sex should not be painful, and women deserve a thorough diagnostic workup and tailored treatment. A multidisciplinary approach may be needed, including consultations with specialized gynecologists, urologists, and pelvic floor physical therapists. Persistent pain is fixable, and repeated opinions are warranted if the first provider is not equipped to help.
Rubin describes a fundamental mismatch in many heterosexual encounters: men seek reassurance about the size, hardness, girth, and duration of their erections, mistakenly believing these factors drive female satisfaction. In reality, women’s pleasure is far more dependent on clitoral stimulation, foreplay, and arousal built through physical and emotional connection.
Women’s arousal styles further differ: spontaneous arousal occurs in only 10–15% of women (compared to 70% of men), while 40–50% of women require responsive arousal once physical contact or foreplay begins. Effective couples prioriti ...
Sexual Function, Anatomy, and Dysfunction
The American medical system consistently fails women, particularly in sexual health, menopause, and hormone therapy. These failures stem from fundamental education gaps, outdated practices, systemic bias, and skewed research priorities—problems that persist regardless of a patient's wealth or access to resources.
Rachel Rubin illustrates that even the wealthiest and most influential women—like Melinda Gates, Oprah Winfrey, and Halle Berry—struggle to obtain competent hormone therapy and accurate menopause diagnosis. Gates had to visit three doctors to get appropriate hormone therapy prescriptions; Oprah saw five physicians who missed her perimenopausal symptoms, and Berry received a misdiagnosis of genital herpes, later revealed to be genitourinary syndrome of menopause. Rubin points out that when the richest women in society can’t access evidence-based information or treatment for their bodies, hormonal health, and sexual health, the situation is much direr for average women.
A glaring symbol of this incompetence is that the word "clitoris" does not exist on the official training checklist for OB-GYNs as of 2026. This omission means most OB-GYNs graduate with no formal education on the clitoris, the vulva, sexual health, sexual pain, libido, arousal, or orgasm. Only a few clinicians seek extra training on their own. As a result, when women and men approach physicians for answers about sexual health, they are likely to encounter providers lacking basic training in these topics.
Rubin describes the exam process: doctors typically cover the patient with a sheet, look at the genitalia, and proceed with procedures like pap smears without engaging or teaching the patient about their own anatomy. She notes that few women (or men) possess even basic language or knowledge about female anatomy because clinicians rarely teach it. In contrast, male sexual anatomy and dysfunction have entire fields dedicated to their care.
Rubin highlights a critical double standard. Even without training or full knowledge of the data, doctors often dictate to women what they can and cannot have regarding hormone therapy, rather than engaging in shared decision-making based on risks and benefits. In men's health, practitioners routinely discuss options openly with patients. Rubin stresses that there is a lost art among doctors in writing hormone therapy prescriptions, understanding the differences between hormone types, and knowing their safety and risks. Despite new societal attention and philanthropic support, such as Melinda Gates giving $10 million to the menopause society, insufficient training means these advances do not reach everyday clinical practice.
Structural limitations also erode quality care. Rubin states it's impossible to provide personalized, nuanced medical advice in a standard 10-minute visit. The time constraint often leads doctors to dismiss complex issues like "not feeling like myself" (NFLM), a common complaint that frequently has a hormonal cause. Rather than exploring these causes, rushed appointments elicit dismissals or default denials of care.
Twenty years of fear and misinformation about hormone therapy created a generation of providers unable to prescribe or explain hormone therapy confidently. Doctors have not been taught how to write these prescriptions, evaluate risk, or distinguish between hormone types, and this knowledge gap persists even as they tell patients what they should or should not have. Even with new research or high-profile funding, there is no system ensuring this information is taught to practicing clinicians or incorporated into medical school or residency curricula.
Although medical research continues to advance, translating this data into clinical reality lags. Rubin notes the massive gap between research being published and practitioners being trained. Despite abundant information about women's sexual health, inadequate educational efforts mean doctors are not using the data—“everyone forgot to teach your doctor.” The lack of infrastr ...
Medical System Failures and Educational Gaps
Open and honest communication, partnered with a willingness to be vulnerable and an investment in ongoing sexual health education, forms the foundation of fulfilling, resilient relationships. Rachel Rubin and Steven Bartlett explore how misunderstandings, medical factors, and lack of dialogue create persistent challenges—and how curiosity, education, and teamwork empower couples to overcome barriers to intimacy.
Many relationship conflicts around sex stem from misinterpreted medical issues. Rubin describes examining women experiencing vulvar pain—sometimes feeling like a sunburn when touched—while a partner is present. By allowing the partner to witness the pain firsthand, she helps reframe sexual avoidance not as rejection or personal inadequacy, but as a valid, treatable condition. This approach builds empathy, dismantles misplaced blame, and encourages both partners to seek solutions together instead of internalizing shame or resentment.
Understanding female arousal, hormones, pelvic floor function, and pain syndromes can help couples identify sources of sexual discomfort and pursue treatment rather than resigning to dissatisfaction or assuming incompatibility. For example, 20-30% of women using hormonal birth control experience decreased libido due to [restricted term] suppression. However, most are unaware that the medication—not a flaw in themselves or their partner—is to blame, leading to unnecessary relational distress.
Both Rubin and Bartlett note that most couples never openly discuss their sex lives. Sensitive topics—orgasm frequency, pain, fantasies, low libido, erectile dysfunction—are buried out of shame or fear, sometimes for years. Women often fake orgasms to please partners, with statistics showing very few women orgasm reliably from penetration within the average duration of intercourse. Men and women hide dissatisfaction or challenges, convinced disclosure would result in rejection or judgment. Yet, Rubin’s experience and Bartlett’s reflections show that voicing vulnerabilities, when handled with care, typically strengthen relationships rather than weaken them.
Missed opportunities for communication often grow into decades-long misunderstandings. One example Bartlett shares is of a friend whose relationship eroded into distant parallel lives after the birth of a child and dwindling intimacy, simply because neither partner initiated a conversation about their needs or struggles. Rubin emphasizes the need for conversations “about sex when you’re not having sex,” suggesting partners debrief after sexual experiences, ask about preferences, and express curiosity spilling into daily life—not just the bedroom.
Therapists or third-party professionals can provide essential support during these conversations, helping manage difficult topics and soften the discomfort of disclosure. Rubin points out that, ironically, people are often more open during a podcast prep session than when talking to their own partner about intimacy.
Contrary to popular belief, sexual spontaneity is rare in long-term relationships. Rubin observes that during dating, couples essentially schedule sexual opportunities—planning dates with anticipation and intention. Once cohabiting, with life’s stresses, exhaustion, and constant exposure to each other’s highs and lows, expecting spontaneous desire sets a standard few can realistically maintain.
She recommends quarterly “partner days,” where couples block off uninterrupted time to reconnect, communicate, and rekindle intimacy, whether or not sex is the explicit goal. These scheduled moments foster playfulness, conversation, and joy—often leading to better sex and renewed connection, far more reliably than waiting for spontaneous desire. For busy couples, overworked parents, or those struggling with burnout, scheduling connection is often the only viable way to maintain intimacy and satisfaction.
Conflicts around libido differences, sexual pain, or mismatched preferences are not moral failings or proof of a bad partner. Rubin and Bartlett emphasize that reframing these issues as shared challenges—“us against the problem”—transforms shame and blame into collaboration and empathy. Recognizing th ...
Communication, Vulnerability, and Education in Relationships
Modern life exerts powerful influences on sexual wellbeing, shaping libido, pleasure, and satisfaction through stress, cultural expectations, and mental health treatments.
Chronic stress, lack of sleep, burnout, and absence of personal downtime significantly drain [restricted term], leading to decreased libido and sexual dissatisfaction. Steven Bartlett describes personal experiences of lowered libido during periods of extreme overwork, noting this is common for many, including women. Rachel Rubin affirms these patterns, explaining that exhausted, overscheduled individuals lack not only the energy but also the mental space needed for sexual connection. She emphasizes this is a lifestyle issue, not a relationship problem or character flaw.
Digital stimulation before bed—such as frequent scrolling, watching porn, or constant media consumption—also depletes the parasympathetic nervous system’s capacity for sexual arousal. Rubin notes that when people consistently consume digital content or are perpetually busy, it erodes the “white space” necessary for desire and connection with partners.
Modern life fosters unrealistic expectations of spontaneous sex, despite little rest or mental space. Rubin suggests scheduling sex as a practical solution for overscheduled couples to intentionally cultivate intimacy.
Perfectionism and insecurity, especially around body image, diminish women’s sexual confidence, pleasure, and participation. Rubin observes that women often invest enormous energy in striving for thinness rather than strength, undermining both vulnerability and sexual self-assurance. Some women withhold intimacy and pleasure from themselves, internalizing appearance-based standards and believing they do not deserve pleasure or orgasm unless they reach a certain weight or look.
Rubin counters these beliefs by applying the standard to others, asking if a best friend—regardless of appearance or weight—deserves fulfilling sex and intimacy. The answer is always yes, reinforcing that all people are entitled to pleasure, intimacy, and connection, and that internalized shame or unrealistic standards should not block full participation in sexual relationships.
Lifestyle and Psychological Factors
Download the Shortform Chrome extension for your browser
